http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017208232-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4829d7791cb1df17cb649e65e789af38
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-194
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-225
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-194
filingDate 2017-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb620c3dda06768bd75cfdbc446513fc
publicationDate 2017-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2017208232-A1
titleOfInvention DIABETES TREATMENT REGIMENS USING α,α-SUBSTITUTED LONG-CHAIN AMPHIPATHIC CARBOXYLATES
abstract Disclosed are methods of treating of type 2 diabetes mellitus and associated conditions in humans by administering an α,α-substituted long-chain dicarboxylic acid. In some of the disclosed methods the α,α-substituted long-chain dicarboxylic acid is administered as add-on therapy to anti-diabetic Standard-of-Care treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11596615-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3761984-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019173640-A1
priorityDate 2016-06-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9830530-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004056740-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5284616
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77999
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396175
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121871
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5585
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444254
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396964
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID150311
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226546166
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441184
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID228005280
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395632
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399756
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394915
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395454
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123915
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41214
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9798144
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226423603
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395203

Total number of triples: 51.